Thus, possible consideration of using acetylcholinesterase inhibitors for syndromes such as Alzheimer’s disease and anticholinergics for overactive bladder will also rise as will the possible health consequences from these antagonistic therapies. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.